|
|
||||
|
Improving vaccines with adenovirus
The Scientist 2005, 19(8):22
|
||||
|
|
||||
|
Researchers at Cornell University's Weill Medical College in New York have created a successful vaccine strategy in mice that uses the immune system's typical antibody response to adenoviruses – which can prevent modified viruses from expressing their payloads and thus diminish the vaccine's efficacy – to boost the antibody response to the vaccine.[1]
|
|
|||||||||
|
|||||||||
|